| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/12/2011 | US20110112142 Novel estrogen receptor ligands |
| 05/12/2011 | US20110112136 Novel process for the manufacture of pharmaceutical preparations |
| 05/12/2011 | US20110112134 Tricyclic Antagonists of Prostaglandin D2 Receptors |
| 05/12/2011 | US20110112127 Compounds and methods for kinase modulation, and indications therefor |
| 05/12/2011 | US20110112126 Enzyme inhibiting compounds |
| 05/12/2011 | US20110112123 Compositions for Intratumoral Administration |
| 05/12/2011 | US20110112112 Apogossypolone derivatives as anticancer agents |
| 05/12/2011 | US20110112111 Drug combinations comprising a dgat inhibitor and a ppar-agonist |
| 05/12/2011 | US20110112110 Antiproliferative compounds and therapeutic uses thereof |
| 05/12/2011 | US20110112108 Pyridazine fungicides |
| 05/12/2011 | US20110112106 Tricyclic inhibitors of 5-lipoxygenase |
| 05/12/2011 | US20110112104 Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them. |
| 05/12/2011 | US20110112102 Method of treating cancer using a neuropeptide y 5r (np y5r) antagonist |
| 05/12/2011 | US20110112099 Therapeutic agent for cancer resistant to protease inhibitor |
| 05/12/2011 | US20110112096 Pyrimidine derivatives as kinase inhibitors |
| 05/12/2011 | US20110112092 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 05/12/2011 | US20110112091 Derivatives of tetrabromobenzimidazole, a process for the preparation thereof, a pharmaceutical composition comprising the same, a methof of using the same, a method for modulating or regulating serine/threonine kinases, and serine/threonine kinases modulating agent |
| 05/12/2011 | US20110112090 Depsipeptides and Their Therapeutic Use |
| 05/12/2011 | US20110112089 Cysteine Protease Inhibitors |
| 05/12/2011 | US20110112087 Thia-triaza-cyclopentazulenes |
| 05/12/2011 | US20110112086 Pyridinone analogs |
| 05/12/2011 | US20110112085 Thiazolopyrimidine pi3k inhibitor compounds and methods of use |
| 05/12/2011 | US20110112084 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/12/2011 | US20110112081 Inhibitors of janus kinases |
| 05/12/2011 | US20110112076 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 05/12/2011 | US20110112069 Purin derivatives for use in the treatment of fab-related diseases |
| 05/12/2011 | US20110112063 Pyrimidine derivatives as kinase inhibitors |
| 05/12/2011 | US20110112061 Pyridazinones, the preparation and the use thereof |
| 05/12/2011 | US20110112058 Novel modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| 05/12/2011 | US20110112054 Organophosphorous Compounds for the Activation of Gamma/Delta T Cells |
| 05/12/2011 | US20110112052 Spiro-oxindole mdm2 antagonists |
| 05/12/2011 | US20110112043 Method of utilizing physiological activity of rare saccharide and composition containing rare saccharide |
| 05/12/2011 | US20110112036 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use |
| 05/12/2011 | US20110111493 Compositions and Methods For Inhibiting Expression Of A Target Gene |
| 05/12/2011 | US20110111073 Recovery of hydrophobic peptides from oils |
| 05/12/2011 | US20110111061 Compositions and Methods for the Treatment of Skeletal Metastatic Lesions and Fractures |
| 05/12/2011 | US20110111059 Compositions Comprising Quinazoline Derivatives, Preparation Methods and Uses Thereof |
| 05/12/2011 | US20110111057 Methods and Compounds Useful to Induce Apoptosis in Cancer Cells |
| 05/12/2011 | US20110111056 Peptide dicer substrate agents and methods for their specific inhibition of gene expression |
| 05/12/2011 | US20110111050 Herbal medicinal composition and herbal medicinal extract for inducing production of peripheral blood stem cells and method for preparing the same |
| 05/12/2011 | US20110111047 Combination preparation of a biological response modifier and an anticancer agent and uses thereof |
| 05/12/2011 | US20110111045 Pharmaceutical composition for preventing and treating cell proliferative disease comprising mixture of feather of birds and scale of fish as an active ingredient |
| 05/12/2011 | US20110111044 Nanoparticle compositions for nucleic acids delivery system |
| 05/12/2011 | US20110111043 Peptides and their use as carriers into cancer cells |
| 05/12/2011 | US20110111033 Hydrogel with covalently crosslinked core |
| 05/12/2011 | US20110111018 Coated tablet formulations and uses thereof |
| 05/12/2011 | US20110110986 High-yield activation of polymer surfaces for covalent attachment of molecules |
| 05/12/2011 | US20110110984 Oral Dosage Form Comprising Tri-Substituted Glycerol Compounds |
| 05/12/2011 | US20110110983 Lactoferrin as an adjuvant in cancer vaccines |
| 05/12/2011 | US20110110979 Method and vaccine for optimizing the specific immune responses |
| 05/12/2011 | US20110110972 Stimulation of an immune response by enantiomers of cationic lipids |
| 05/12/2011 | US20110110970 Chimeric vaccines |
| 05/12/2011 | US20110110959 Anti-p2x7 peptides and epitopes |
| 05/12/2011 | US20110110958 Compositions and methods for the treatment of neoplasia |
| 05/12/2011 | US20110110956 Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding Proteins |
| 05/12/2011 | US20110110955 Antibody cancer immunotherapy |
| 05/12/2011 | US20110110952 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 05/12/2011 | US20110110951 Isolation of five novel genes coding for new fc receoptrs-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 05/12/2011 | US20110110950 Therapeutic regimens for BAFF antagonists |
| 05/12/2011 | US20110110947 Viral chemokine-antigen fusion proteins |
| 05/12/2011 | US20110110946 Soluble receptor br43x2 and methods of using |
| 05/12/2011 | US20110110944 Anti-alk1 antibodies and uses thereof |
| 05/12/2011 | US20110110941 Wortmannin Analogs and Methods of Using Same in Combination with Chemotherapeutic Agents |
| 05/12/2011 | US20110110940 Methods for Enhancing the Efficacy of Vascular Disrupting Agents |
| 05/12/2011 | US20110110936 Anti-gcc antibody molecules and related compositions and methods |
| 05/12/2011 | US20110110931 Methods for Detecting and Monitoring Circulating Cancer Stem Cells |
| 05/12/2011 | US20110110929 Human anti-idiotypic antibody fragments that mimic her-2/neu |
| 05/12/2011 | US20110110926 Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants |
| 05/12/2011 | US20110110925 Compositions and Methods for the Treatment and Diagnosis of Cancer |
| 05/12/2011 | US20110110923 Fish assay for eml4 and alk fusion in lung cancer |
| 05/12/2011 | US20110110917 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis |
| 05/12/2011 | US20110110915 14189, a novel human kinase and uses thereof |
| 05/12/2011 | US20110110914 Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| 05/12/2011 | US20110110913 Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders |
| 05/12/2011 | US20110110911 Methods of Treating Cancer Using Tachykinin Retargeted Endopepidases |
| 05/12/2011 | US20110110909 Human facilitating cells |
| 05/12/2011 | US20110110907 Composition of soluble indigestible fibers and of eukaryotic organisms with a polysaccharide wall, used in the well-being field |
| 05/12/2011 | US20110110901 Methods of long-term culture of eukaryotic cells and uses thereof |
| 05/12/2011 | US20110110896 Modulating levels of RNA-binding proteins for the treatment of breast cancer |
| 05/12/2011 | US20110110893 Therapeutic agent for anaerobic diseases |
| 05/12/2011 | US20110110889 Raf inhibitor compounds and methods of use thereof |
| 05/12/2011 | US20110110886 Small molecule inhibitors of autotaxin and methods of use |
| 05/12/2011 | US20110110885 Bioactive Depside and Anthocyanin Compounds, Compositions, and Methods of Use |
| 05/12/2011 | US20110110884 Immunotherapy for immune suppressed patients |
| 05/12/2011 | US20110110883 Methods of altering an immune response induced by cpg oligodeoxynucleotides |
| 05/12/2011 | US20110110881 Liquid composition of cisplatin coordination compound |
| 05/12/2011 | US20110110868 Functionalized Magnetic Nanoparticles and Methods of Use Thereof |
| 05/12/2011 | US20110110866 Elastin-like polypeptide and gadolinium conjugate for magnetic resonance imaging |
| 05/12/2011 | US20110110861 Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells |
| 05/12/2011 | US20110110859 Protein |
| 05/12/2011 | US20110110856 Optimized Adhesin Fragments And Corresponding Nanoparticles |
| 05/12/2011 | US20110110855 Novel ghrelin analogues |
| 05/12/2011 | US20110110852 Multivalent Antibodies and Uses Therefor |
| 05/12/2011 | US20110110851 Multivalent Immunoglobulin-Based Bioactive Assemblies |
| 05/12/2011 | DE102009053157A1 Arzneimittel enthaltend Cholin Medicines containing choline |
| 05/12/2011 | CA2816437A1 Antibodies that specifically block the biological activity of kidney associated antigen 1 |
| 05/12/2011 | CA2780199A1 Pharmaceutical composition containing choline |
| 05/12/2011 | CA2780145A1 Therapeutic compounds |
| 05/12/2011 | CA2780136A1 Compounds inhibitors of enzyme lactate dehydrogenase (ldh) and pharmaceutical compositions containing these compounds |
| 05/12/2011 | CA2779951A1 Imidazopyridine derivatives |